Literature DB >> 15939048

Complementary therapies for peripheral arterial disease: systematic review.

Max H Pittler1, Edzard Ernst.   

Abstract

While peripheral arterial disease (PAD) affects a considerable proportion of patients in the primary care setting, there is a high level of use of complementary treatment options. The aim was to assess the effectiveness of any type of complementary therapy for peripheral arterial disease. A systematic review was performed. Literature searches were conducted on Medline, Embase, Amed, and the Cochrane Library until December 2004. Hand-searches of medical journals and bibliographies were conducted. There were no restrictions regarding the language of publication. The screening of studies, selection, data extraction, the assessment of methodologic quality and validation were performed independently by the two reviewers. Data from randomized controlled trials, and systematic reviews and meta-analyses, which based their findings on the results of randomized controlled trials were included. Seven systematic reviews and meta-analyses and three additional randomized controlled trials met the inclusion criteria and were reviewed. The evidence relates to acupuncture, biofeedback, chelation therapy, CO(2)-applications and the dietary supplements Allium sativum (garlic), Ginkgo biloba (ginkgo), omega-3 fatty acids, padma 28 and Vitamin E. Most studies included only patients with peripheral arterial disease in Fontaine stage II (intermittent claudication). The reviewed RCTs, systematic reviews and meta-analyses which based their findings on the results of RCTs suggest that G. biloba is effective compared with placebo for patients with intermittent claudication. Evidence also suggests that padma 28 is effective for intermittent claudication, although more data are required to confirm these findings. For all other complementary treatment options there is no evidence beyond reasonable doubt to suggest effectiveness for patients with peripheral arterial disease.

Entities:  

Mesh:

Year:  2005        PMID: 15939048     DOI: 10.1016/j.atherosclerosis.2005.02.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical field.

Authors:  Johanna M Gostner; Oliver A Wrulich; Marcel Jenny; Dietmar Fuchs; Florian Ueberall
Journal:  BMC Complement Altern Med       Date:  2012-03-14       Impact factor: 3.659

2.  Medical Resource Consumption and Quality of Life in Peripheral Arterial Disease in Korea: PAD Outcomes (PADO) Research.

Authors:  Seung Woon Rha; Seung Hyuk Choi; Doo Il Kim; Dong Woon Jeon; Jae Hwan Lee; Kyung Soon Hong; Tae Joon Cha; Jang Hyun Cho; Sang Kon Lee; Yong Hwan Park; Woo Jung Park; Hyun Joo Kim; Young Joo Kim; Juneyoung Lee; Donghoon Choi
Journal:  Korean Circ J       Date:  2018-06-18       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.